Tag: AstraZeneca
Broaden evaluation of foreign investors’ intentions, urges EEF
Plans to broaden takeover rules should go much further, covering the impact of foreign investor-led deals on UK supply chains and skills base, says lobby group EEF.
Shareholder displeasure against S&P500 directors reaches high level
Withholding of votes reaches peak level, sending a signal that shareholders are unhappy with S&P500 directors.
AstraZeneca shareholders signal concerns over pay
Almost 40% of AstraZeneca shareholders deliver a blow to the pharmaceuticals company, by voting against its annual remuneration report.